找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Chemoprevention; Volume 2: Strategies Gary J. Kelloff,Ernest T. Hawk,Caroline C. Sigman Book 2005 Humana Press 2005 carcinoma.endosc

[復(fù)制鏈接]
查看: 33552|回復(fù): 60
樓主
發(fā)表于 2025-3-21 19:24:28 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cancer Chemoprevention
副標(biāo)題Volume 2: Strategies
編輯Gary J. Kelloff,Ernest T. Hawk,Caroline C. Sigman
視頻videohttp://file.papertrans.cn/222/221070/221070.mp4
概述Includes supplementary material:
叢書名稱Cancer Drug Discovery and Development
圖書封面Titlebook: Cancer Chemoprevention; Volume 2: Strategies Gary J. Kelloff,Ernest T. Hawk,Caroline C. Sigman Book 2005 Humana Press 2005 carcinoma.endosc
描述Despite significant advances in cancer treatment and measures of neoplastic progression, drug effect (or early detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy. cancer survival has remained relatively flat over the past All these biomarkers have the potential to greatly augment several decades (1,2). However, new technology the development of successful chemoprevention therapies, allowing exploration of signal transduction pathways, but two specific types of biomarkers will have the most identification of cancer-associated genes, and imaging of immediate impact on successful chemopreventive drug tissue architecture and molecular and cellular function is development—those that measure the risk of developing increasing our understanding of carcinogenesis and cancer invasive life-threatening disease, and those whose mo- progression. This knowledge is moving the focus of cancer lation can “reasonably predict” clinical benefit and, therapeutics, including cancer preventive treatments, to therefore, serve as surrogate end
出版日期Book 2005
關(guān)鍵詞carcinoma; endoscopy; imaging; morbidity; positron emission tomography
版次1
doihttps://doi.org/10.1007/978-1-59259-768-0
isbn_softcover978-1-62703-817-1
isbn_ebook978-1-59259-768-0Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightHumana Press 2005
The information of publication is updating

書目名稱Cancer Chemoprevention影響因子(影響力)




書目名稱Cancer Chemoprevention影響因子(影響力)學(xué)科排名




書目名稱Cancer Chemoprevention網(wǎng)絡(luò)公開度




書目名稱Cancer Chemoprevention網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Chemoprevention被引頻次




書目名稱Cancer Chemoprevention被引頻次學(xué)科排名




書目名稱Cancer Chemoprevention年度引用




書目名稱Cancer Chemoprevention年度引用學(xué)科排名




書目名稱Cancer Chemoprevention讀者反饋




書目名稱Cancer Chemoprevention讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:01:16 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:05:27 | 只看該作者
地板
發(fā)表于 2025-3-22 08:20:19 | 只看該作者
Management of Neurogenic Overactive Bladdera, Wilms tumor, osteosarcoma, testicular cancer, Hodgkin’s disease, diffuse large B cell lymphoma, and other neoplasms. Mortality for breast cancer has been reduced as a result of improvements in chemoprevention, early detection, and therapy. For many other solid tumors, however, progress has been more limited.
5#
發(fā)表于 2025-3-22 12:36:27 | 只看該作者
Evaluation of Spasticity in Adultsrts from epidemiologic observational studies, preclinical studies, and biomarker-based trials, the number of Phase III (randomized, placebo-controlled) trials has remained relatively small because of the large number of subjects required, the long duration of study, and the high cost of these studies.
6#
發(fā)表于 2025-3-22 16:17:41 | 只看該作者
https://doi.org/10.1007/978-1-59259-768-0carcinoma; endoscopy; imaging; morbidity; positron emission tomography
7#
發(fā)表于 2025-3-22 17:16:02 | 只看該作者
8#
發(fā)表于 2025-3-22 23:12:53 | 只看該作者
9#
發(fā)表于 2025-3-23 02:05:08 | 只看該作者
M. Sindou M.D., D.Sc. Biol.,M. F. Milletancer were estimated to be diagnosed in the United States (US), and about 555,500 persons were expected to die of cancer, i.e., more than 1500 every day (.). Despite small decreases in overall cancer incidence and mortality rates in the US since the early 1990s, the total number of recorded cancer d
10#
發(fā)表于 2025-3-23 09:32:35 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 10:28
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
塔河县| 南靖县| 旬邑县| 胶州市| 江陵县| 无极县| 松江区| 淳安县| 诸暨市| 大埔区| 龙江县| 镇沅| 伊川县| 荆州市| 禹州市| 新建县| 云和县| 富平县| 明光市| 哈巴河县| 洪雅县| 海丰县| 长垣县| 绩溪县| 宣威市| 泗阳县| 保亭| 怀远县| 周口市| 休宁县| 金华市| 邹平县| 英超| 兴文县| 乐业县| 绥棱县| 墨脱县| 洪泽县| 炎陵县| 静海县| 石城县|